UBS’s NuVasive, Inc. NUVA Stock Holding History

UBS’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-200	Closed	-$5K	–	10792
2013 Q2	$5K	Buy	+200	New	+$4.38K	﹤0.01%	9275

Other funds holding NUVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

UBS's NUVA Position: Q3 2014 in Review

UBS held its NuVasive, Inc. (NUVA) position steady in Q3 2014 at 19,430 shares worth $678K. The position accounts for ﹤0.01% of the portfolio, ranked #3983.

UBS first reported a position in NUVA in Q2 2013 and has held it in 6 quarters since. The position peaked at $888K in Q1 2014. 182 funds tracked by Wall St. Rank hold NUVA as of Q3 2014.

UBS held 19,430 shares of NuVasive, Inc. worth $678K as of Q3 2014.
UBS left its NuVasive, Inc. share count unchanged in Q3 2014.
NuVasive, Inc. made up ﹤0.01% of UBS's portfolio in Q3 2014, its #3983 holding.
UBS first reported a position in NuVasive, Inc. in Q2 2013 and has held it in 6 quarters since.
UBS's NuVasive, Inc. position peaked at $888K in Q1 2014.
182 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.